Novo Nordisk said on Thursday it would offer temporary discounts to cash-paying customers for its weight-loss drug Wegovy, in ...

Shares of Humana and other health insurers fell Thursday after the Centers for Medicare & Medicaid Services said it plans to ...

The focus of the lawsuit is forfeited funds, which total the amount of employer match contributions participants lose if they ...

Experts say it's no surprise that UnitedHealthcare often ends up in the crosshairs of public and political scrutiny, as it's ...

U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...

Cigna has announced a deal to cap client copays on popular GLP-1 weight loss drugs by Eli Lilly and Novo Nordisk at $200 per ...

Evernorth said that through direct negotiations with Novo Nordisk and Eli Lilly, patients’ monthly copay costs for Wegovy (semaglutide) and Zepbound (tirzepatide) will not exceed $200. Wegovy has a ...

Cigna’s (NYSE:CI) health services arm, Evernorth, has launched a pharmacy benefit program that caps out-of-pocket costs at ...

Cigna’s Evernorth unit scored a deal with Eli Lilly and Novo Nordisk to make weight loss drugs more affordable for insured ...

The stock's fall snapped a five-day winning streak.

Cigna Group’s drug benefit unit is offering a new way for health plans to cover expensive weight-loss drugs that it says will ...

Cigna's Evernorth is rolling out a new pharmacy benefit management program that caps members' monthly cost for key GLP-1 ...